Rui Cui

机构：Tianjin First Center Hospital, Tianjin Medical University · ORCID：0000-0002-4994-5262

发表论文 85 篇 · 总被引 849 次 · h-index 14

代表论文

• CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis (2024 · Cancer Cell · 被引 197)
• Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects (2024 · Cell Transplantation · 被引 4)
• Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL (2023 · Annals of Hematology · 被引 4)
• De novo AML spontaneously achieved PR after COVID-19 infection, and CR after reduced dose of azacytidine combined with venetoclax: A case report and literature review (2025 · Medicine · 被引 3)
• The application of optogenetics in traumatic brain injury research: A narrative review (2024 · Brain Circulation · 被引 3)
• Efficacy and side effects of anti‐CD19 CAR T‐cell therapy in patients with relapsed/refractory gastrointestinal lymphoma (2024 · Cancer Medicine · 被引 2)